31 Mar 2023 11:00 CEST

Bergen, Norway 31 March 2023

The Annual General Meeting (“AGM”) of Lifecare AS will be held on 18 April 2023
at 10:00 CET. Notice of the AGM is enclosed to this announcement. Documents for
the AGM are available at www.lifecare.no/events/.

The meeting will be conducted as a combined in-person and digital meeting.
Shareholders who wish to participate and vote at the General Meeting must be
registered with a user profile in the meeting portal Orgbrain (www.orgbrain.no).
It will be possible to attend the meeting in-person at Lifecare's main office or
digitally through Orgbrain. Further information about participation and
registration appears from the notice.

_____

This is Lifecare
Lifecare AS is a clinical stage medical sensor company developing technology for
sensing and monitoring of various body analytes. Lifecare’s main focus is to
bring the next generation of Continuous Glucose Monitoring systems to market.
Lifecare enables osmotic pressure as sensing principle, combined with the
ability to manipulate Nano-granular Tunnelling Resistive sensors on the sensor
body for read-out of pressure variations. Lifecare´s sensor technology is
referred to as “Sencell” and is suitable for identifying and monitoring the
occurrence of a wide range of analytes and molecules in the human body.
______

Further information
Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act. This stock exchange announcement was
published by Joacim Holter, CEO at Lifecare AS, on 31 March 2023 at 11:00 CET.


586871_Notice AGM .pdf

Source

Lifecare AS

Provider

Oslo Børs Newspoint

Company Name

LIFECARE

ISIN

NO0010591191, NO0013355859

Symbol

LIFE

Market

Euronext Growth